200 related articles for article (PubMed ID: 32049407)
41. The use of imiquimod in the treatment of periocular tumours.
Ross AH; Kennedy CT; Collins C; Harrad RA
Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
[TBL] [Abstract][Full Text] [Related]
42. Coexisting perianal squamous cell carcinoma, Bowen's disease, and condylomata acuminata treated with topical imiquimod 5%.
Murua AA; González LC; García-Río I; Urra IT; Michelena IA; González-Pérez R; Santarén BC; Arechavala RS
Int J Dermatol; 2008 Dec; 47(12):1334-6. PubMed ID: 19126041
[No Abstract] [Full Text] [Related]
43. Pagetoid Bowen's disease of vulva: Excellent response to imiquimod.
Yadav P; Mendiratta V; Rana S; Makhija M
Indian J Dermatol Venereol Leprol; 2016; 82(6):734-737. PubMed ID: 27506507
[No Abstract] [Full Text] [Related]
44. Occlusive medication with imiquimod in Bowen's disease.
Muzio G; Ciambellotti A; Rebora A
Acta Derm Venereol; 2004; 84(2):168-9. PubMed ID: 15206706
[No Abstract] [Full Text] [Related]
45. Bowen's disease in a renal transplant recipient treated with a single application of topical imiquimod: severe adverse skin reaction with favourable clinical outcome.
Casanova D; Martignoni G; Boccaletti V; Di Nuzzo S
Acta Biomed; 2012 Apr; 83(1):81-3. PubMed ID: 22978064
[No Abstract] [Full Text] [Related]
46. Pigmented Bowen's disease of the digit successfully treated with imiquimod 5% cream.
Yanagishita T; Akita Y; Nakanishi G; Tamada Y; Watanabe D
Eur J Dermatol; 2011; 21(6):1021-2. PubMed ID: 21951362
[No Abstract] [Full Text] [Related]
47. Hearing loss in association with topical imiquimod use for squamous cell carcinoma in situ (Bowen disease).
Rodrigues M; Gamboni SE; Cousins VC; Nixon RL
Australas J Dermatol; 2016 Nov; 57(4):323-324. PubMed ID: 27885662
[No Abstract] [Full Text] [Related]
48. Therapeutic options for Bowen's disease.
Moreno G; Chia AL; Lim A; Shumack S
Australas J Dermatol; 2007 Feb; 48(1):1-8; quiz 9-10. PubMed ID: 17222293
[TBL] [Abstract][Full Text] [Related]
49. Combination therapy with imiquimod, 5-fluorouracil, and tazarotene in the treatment of extensive radiation-induced Bowen's disease of the hands.
Modi G; Jacobs AA; Orengo IF; McClung A; Rosen T
Dermatol Surg; 2010 May; 36(5):694-700. PubMed ID: 19732103
[No Abstract] [Full Text] [Related]
50. Topical therapy with imiquimod for eyelid lesion.
Tsang HH; Huynh NT; Hollenbach E
Clin Exp Ophthalmol; 2006 Mar; 34(2):179-81. PubMed ID: 16626439
[TBL] [Abstract][Full Text] [Related]
51. Eruptive keratoacanthoma following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient.
Pini AM; Koch S; Schärer L; French LE; Läuchli S; Hofbauer GF
J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S116-7. PubMed ID: 19119118
[No Abstract] [Full Text] [Related]
52. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream.
Schroeder TL; Sengelmann RD
J Am Acad Dermatol; 2002 Apr; 46(4):545-8. PubMed ID: 11907505
[TBL] [Abstract][Full Text] [Related]
53. [Recurrent Bowen's disease of the nail: treatment by topical imiquimod (Aldara)].
Laffitte E; Saurat JH
Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):211-3. PubMed ID: 12671589
[No Abstract] [Full Text] [Related]
54. Bowen's disease of shaft of penis. Successful treatment with 5-fluorouracil.
Tolia BM; Castro VL; Mouded IM; Newman HR
Urology; 1976 Jun; 7(6):617-9. PubMed ID: 936382
[TBL] [Abstract][Full Text] [Related]
55. Treatment of giant Bowen's disease with sequential use of photodynamic therapy and imiquimod cream.
Sotiriou E; Lallas A; Apalla Z; Ioannides D
Photodermatol Photoimmunol Photomed; 2011 Jun; 27(3):164-6. PubMed ID: 21535173
[TBL] [Abstract][Full Text] [Related]
56. Cryosurgery during imiquimod cream treatment ("immunocryosurgery") for Bowen's disease of the skin: a case series.
Gaitanis G; Mitsou G; Tsiouri G; Alexis I; Bassukas ID
Acta Derm Venereol; 2010 Sep; 90(5):533-4. PubMed ID: 20814639
[No Abstract] [Full Text] [Related]
57. Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients.
Prinz BM; Hafner J; Dummer R; Burg G; Bruswanger U; Kempf W
Transplantation; 2004 Mar; 77(5):790-1. PubMed ID: 15021851
[No Abstract] [Full Text] [Related]
58. Treatment of Bowen Disease With Photodynamic Therapy and the Advantages of Sequential Topical Imiquimod.
Victoria-Martínez AM; Martínez-Leborans L; Ortiz-Salvador JM; Pérez-Ferriols A
Actas Dermosifiliogr; 2017 Mar; 108(2):e9-e14. PubMed ID: 27377937
[TBL] [Abstract][Full Text] [Related]
59. Topical 5% imiquimod eliminated human papillomavirus 16-associated Bowen's disease.
Nishimura M; Fujita M; Mitsuishi T
J Dermatol; 2017 Mar; 44(3):e25-e26. PubMed ID: 27451297
[No Abstract] [Full Text] [Related]
60. A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
Aguilar M; de Troya M; Martin L; Benítez N; González M
J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1431-6. PubMed ID: 20456549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
